甲基胺戒断者的"冷"和"热"的前性反应抑制抑制
Shu-Ho Chen1, Ming-Hong Hsieh2,3, Chieh-Liang Huang4
1Department of Psychology, Chung-Shan Medical University, Taichung, Taiwan.
对于戒除甲基胺 (MA) 的人来说,改善的抑制控制与更长的戒断时间有关,而不是成的严重程度. 这表明,针对认知控制的干预措施可能有助于恢复并降低复发风险.
科学领域:
- 神经科学是一个神经科学.
- 心理学 心理学 心理学
- 成研究 研究成研究
背景情况:
- 滥用甲基胺 (MA) 是台湾的一个重大公共卫生问题.
- 抑制控制受损是导致MA成复发的关键因素.
- 关于MA戒断者的抑制控制缺陷的研究,特别是在不同的背景下,是有限的.
研究的目的:
- 为了研究与健康对照组相比,MA戒断者中抑制前性反应.
- 在中性 ("冷") 和与药物有关的 ("热") 背景下检查抑制控制.
- 探索抑制控制与禁欲持续时间和成严重程度等因素之间的关系.
主要方法:
- 一个修改后的抗动任务被采用了"冷" (中性图像) 和"热" (MA相关图像) 条件.
- 24名男性禁食者和24名健康对照参与了这项研究.
- 评估了前性反应抑制,并分析了与临床变量之间的相关性.
主要成果:
- 在MA戒断者和健康对照者之间,在各种条件下,没有发现抑制前性反应的显著差异.
- 在MA戒断者中,增强的前性反应抑制与更长的戒断时间正相关.
- 抑制性控制与戒断者中的严重程度,治疗持续时间或过去使用史无关.
结论:
- 在MA戒断者中,前性反应抑制与戒断的持续时间比与长期成严重程度或治疗史更强烈相关.
- 专注于增强抑制控制的干预措施可能有利于降低复发风险并改善MA戒断者的康复结果.
更多相关视频
08:05A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers
Published on: January 5, 2018
09:16A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
相关概念视频
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Desensitization and Tachyphylaxis
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
